Company intelligence / Profile preview

ALCOA CRO

Istanbul, Istanbul Province, Turkeymosio.com ↗

Ownership: Private
Development stage: Other

Overview

ALCOA CRO is a recently established contract research organization based in Istanbul. Founded in 2024 by Dr. Hakan Kaptanoğulları and industry veterans, the company provides high-quality and ethical clinical research services for pharmaceutical and biotechnology clients. Its mission centers on transparency, excellence, patient-centered approaches, and strict adherence to regulatory standards. The company aims to become a global player in clinical research by advancing healthcare standards through innovation and collaboration

Modalities: Small moleculeBiologicMonoclonal antibody
Industry: Contract Research Organization

Beyond the preview

Go deeper on ALCOA CRO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALCOA CRO.

Explore the full profile